Immutep up 8pc as FDA gives therapy nod

MELBOURNE: Immunotherapy biotech Immutep shares surged 8 per cent in trade on Monday, ...

To read the full story...SUBSCRIBE NOW

Existing Subscribers Login Below:

Log In